Winton Group LTD Nektar Therapeutics Transaction History

Winton Group LTD

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$15.77 - $19.03 $720,483 - $869,423	-45,687 Closed	0 $0
Q3 2020 Oct 30, 2020	SELL	$16.59 - $24.79 $938,131 - $1.4 Million	-56,548 Reduced 55.31%	45,687 $758,000
Q2 2020 Aug 05, 2020	SELL	$16.86 - $23.44 $177,384 - $246,612	-10,521 Reduced 9.33%	102,235 $2.37 Million
Q1 2020 May 11, 2020	SELL	$14.47 - $27.96 $2.03 Million - $3.93 Million	-140,502 Reduced 55.48%	112,756 $2.01 Million
Q4 2019 Feb 13, 2020	BUY	$15.87 - $23.12 $3.23 Million - $4.7 Million	203,417 Added 408.13%	253,258 $5.47 Million
Q3 2019 Nov 08, 2019	BUY	$16.91 - $36.27 $719,655 - $1.54 Million	42,558 Added 584.35%	49,841 $908,000
Q2 2019 Jul 08, 2019	BUY	$31.0 - $36.3 $16,492 - $19,311	532 Added 7.88%	7,283 $259,000
Q1 2019 May 13, 2019	SELL	$31.58 - $46.35 $108,729 - $159,583	-3,443 Reduced 33.77%	6,751 $227,000
Q4 2018 Feb 05, 2019	BUY	$30.43 - $56.65 $89,129 - $165,927	2,929 Added 40.32%	10,194 $335,000
Q3 2018 Nov 02, 2018	SELL	$46.46 - $68.49 $19,513 - $28,765	-420 Reduced 5.47%	7,265 $0
Q2 2018 Aug 20, 2018	BUY	$46.25 - $104.45 $103,507 - $233,759	2,238 Added 41.09%	7,685 $0
Q1 2018 May 21, 2018	BUY	$57.4 - $108.44 $312,657 - $590,672	5,447 New	5,447 $0

145

139M

32.6K

14.1K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $146M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.